Skip to main content

Bioelectric Medicine Market Size Worth USD 44.59 Billion in 2032 | Emergen Research

The growth of the Bioelectric Medicine market is attributed to the increasing number of consumer friendly reimbursement policies and rising number of hronic ailments

Vancouver, Nov. 23, 2023 (GLOBE NEWSWIRE) — The global Bioelectric Medicine Market will be worth USD 44.59 billion by 2032 , according to a current analysis by Emergen Research. The growth of the market across the globe is majorly attributed to the key driving factors like increasing geriatric population which often leads to a spike in the requirement of bioelectric medicine, growing dependency of diseases inciting the utilization of bioelectric medicine, increasing frequency and number of investments and funds targeted towards the R&D of novel therapeutics and electroceuticals, leading to restricted rate of success of medicines focusing on the treatment of specific disease, growing number of reactions to drugs, and rise in the levels of awareness among consumers.

The market is anticipated to grow at a considerable rate mainly because of the opportunities that are with the reach of its domain, which also includes growth in developing economies coupled with technological advancement in bioelectric medicine. Given the aforesaid factors, there are a handful of restraining factors which are hampering the market growth. These challenges extend to product recall, stringent scrutiny procedures when it comes to regulatory policies, exorbitant cost of electroceuticals, and side effects and complications associated with the bioelectric medicine devices.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/266

Segments Covered in the report

Report DetailsOutcome
The market size value in 2019USD 17.42 Billion
CAGR (2023 – 2032)7.5%
The revenue forecast in 2032USD 44.59 Billion
Base year for estimation2022
Historical data2019 – 2021
Forecast period2023 – 2032
Quantitative unitsRevenue in USD Billion, and CAGR from 2023 to 2032
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments coveredProduct Type, Application, End User, Region
Regional scopeNorth America; Europe; Asia Pacific; Central and South America; MEA
Country scopeU.S.; Canada; Mexico; U.K.; Germany; France; Italy; Spain; China; India; Japan; South Korea; Brazil; Saudi Arabia; South Africa; Turkey
Key companies profiledMedtronic, Abbott, Boston Scientific, Cochlear Ltd., Siemens Healthineers AG, Biotronik, LivaNova Plc, ElectroCore Inc, Nevro Corp., Sonova
Customization scope10 hrs of free customization and expert consultation

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/266

MAJOR COMPANIES and Market Share Analysis

The market for Bioelectric Medicine is highly fragmented with a large number of small as well as medium-sized manufacturers, which account for a major global share of the market. The manufacturers involved in the Bioelectric Medicine Market are desegregated across the value chain.

Some of the prominent players in the Bioelectric Medicine Market include:

  • Medtronic Plc.
  • Boston Scientific Corporation
  • St. Jude Medical
  • Cochlear Ltd.
  • LivaNova PLC
  • Sonova
  • Biotronik
  • Second Sight
  • Nevro Corp.
  • ElectroCore

Strategic Development

  • US based Boston Scientific Corporation acquired Vertiflex, Inc. in June 2019. Vertiflex mainly focuses on minimally invasive technology which aids in alleviating pain, thereby restoring the usual physical functionalities of lumbar spinal stenosis. It is anticipated that the deal is likely to strengthen radiofrequency ablation portfolio and spinal cord stimulation.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/266

Key Highlights from The Report.

  • In March 2019, Novocure, a U.S.-based electroceutical developer, received the approval from FDA for their patented bioelectric brain stimulators which can be utilized is close association with the existing chemotherapy.
  • The bioelectric medical devices are mostly wearables which are implanted internally or externally in the body. The majority of these devices are designed in a way to stimulate the vagus nerve in the human body to keep in track with the patient’s lungs breathing and heart beating. The vagal nerve stimulators and devices which are mainly used to diagnose depression and epilepsy are implants, which makes the products easy to use. This ease of usage is a factor which also stimulates the growth of the market.
  • The major competitors operating in the industry are frequently involved in new product developments in order to increase the portfolio. Additionally, they also concentrate of collaborations, mergers, and acquisitions with technology companies especially biotech companies. The organizations also focus on regional expansions in order to gain maximum revenue share in the sector. All these initiatives are in turn propelling the market valuation on a global scale.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/bioelectric-medicine-market

For the purpose of this report, Emergen Research has segmented into the global Bioelectric Medicine Market on the product type, application, end user and region:

  • Product Type Outlook (Revenue, USD Billion; 2019-2032)
  • Cardioverter defibrillators
  • Cardiac pacemakers
  • Cohlear implants
  • Spinal cord stimulators
  • Brain stimulators
  • Sacral and vagus nerve stimulator
  • Application Outlook (Revenue, USD Billion; 2019-2032)
  • Arrhythmia
  • Pain Management
  • Sensorineural hearing loss
  • Parkinson’s disease
  • Tremor
  • Depression
  • End User Outlook (Revenue, USD Billion; 2019-2032)
  • Hospitals
  • Ambulatory Surgery Centers
  • Diagnostic Centers
  • Regional Outlook (Revenue: USD Billion; 2019-2032)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. UK
      2. Germany
      3. France
      4. BENELUX
      5. Rest of Europe
    • Asia Pacific
      1. China
      2. Japan
      3. South Korea
      4. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • MEA
      1. Saudi Arabia
      2. UAE
      3. Rest of MEA

Curated Reports You Shouldn’t Miss: Dive In Now!

Electrotherapy Market By Treatment Type (Transcutaneous Spinal Electro analgesia (TSE), Interferential Current Therapy (IC), Pulsed Short Wave Diathermy (PSWD), Transcutaneous Electrical Nerve Stimulation (TENS), Spinal Cord Stimulation (SCS), Electro-Acupuncture (EA), Percutaneous Electrical Nerve Stimulation (PENS), Others), By Application (Sports Injury, Neuromuscular Dysfunction, Tissue Repair, Urine and Fecal Incontinence, Iontophoresis, Pain Management, Acute and Chronic Edema), By End-Use (Rehabilitation Centers, Long-term Care Centers, Clinics Hospitals, Others), By Region Forecast to 2028

Oncolytic Virus Therapy Market By Type (Monoclonal Antibodies, Checkpoint Inhibitors, Cancer Vaccines, Immunomodulators), By Application (Melanoma, Lung Cancer, Breast Cancer), By End-Use (Hospitals, Clinics, Research Institutes), and By Region, Forecast to 2028

Wearable Injectors Market By Technology (Motor-driven. Spring-based), By Type (Off-body, On-body), By Application (Cardiovascular Disease, Diabetes, Immuno-oncology), By End-use (Hospitals, Home Care Settings), and By Region, Forecast to 2028

Blood Pressure Monitoring Devices Market By Product Type (Sphygmomanometer, Digital Blood Pressure Monitor, Ambulatory Blood Pressure Monitor, Instruments & Accessories, Transducers) By Technology (Air Pressure-based, Sensor-based), By End-Use (Hospitals and Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Homecare Settings, Others), and By Region Forecast to 2028

Interventional Cardiology Devices Market By Product Type (Angioplasty Stents, Angioplasty Balloons, Catheters, Structural Heart Devices, Plaque Modification Devices, Guidewires, Hemodynamic Flow Alteration Devices), By End-Use (Hospitals, Ambulatory Surgical Centers), and By Region, Forecast to 2028

Eubiotics Market By Product (Probiotics, Prebiotics, Organic Acids, Essential Oils, Exogenous Enzymes), By Form (Solid, Liquid), By Application (Gut Health, Yield, Immunity, Production), By End-Use (Poultry, Swine, Ruminant, Aquaculture), and By Region, Forecast to 2028

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Japanese Version: Bioelectric Medicine Market

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

Read our Press Release @ https://www.emergenresearch.com/press-release/global-bioelectric-medicine-market

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.